• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inefficacy of platelet transfusion to reverse ticagrelor.

作者信息

Godier Anne, Taylor Guillaume, Gaussem Pascale

机构信息

Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

出版信息

N Engl J Med. 2015 Jan 8;372(2):196-7. doi: 10.1056/NEJMc1409373.

DOI:10.1056/NEJMc1409373
PMID:25564918
Abstract
摘要

相似文献

1
Inefficacy of platelet transfusion to reverse ticagrelor.血小板输注无法逆转替格瑞洛的作用。
N Engl J Med. 2015 Jan 8;372(2):196-7. doi: 10.1056/NEJMc1409373.
2
Inefficacy of Platelet Transfusion in a Heart Transplant Patient Under Continuous Ticagrelor.
J Cardiothorac Vasc Anesth. 2017 Oct;31(5):1776-1778. doi: 10.1053/j.jvca.2017.02.180. Epub 2017 Feb 20.
3
Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison.普拉格雷与替格瑞洛用于急性冠状动脉综合征的随机对照比较
Int J Cardiol. 2013 Dec 10;170(2):e21-2. doi: 10.1016/j.ijcard.2013.10.043. Epub 2013 Oct 14.
4
Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patients.替格瑞洛相关性呼吸困难对急性冠脉综合征患者治疗依从性的影响。
Int J Cardiol. 2014 Apr 15;173(1):120-1. doi: 10.1016/j.ijcard.2014.02.028. Epub 2014 Feb 22.
5
Ticagrelor related dyspnea in patients with acute coronary syndromes: Incidence and implication on ticagrelor withdrawn.急性冠脉综合征患者中替格瑞洛相关呼吸困难：发生率及对停用替格瑞洛的影响
Int J Cardiol. 2015;187:517-8. doi: 10.1016/j.ijcard.2015.03.417. Epub 2015 Mar 31.
6
Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromes.替格瑞洛：用于急性冠脉综合征治疗的口服可逆性 P2Y(12)受体拮抗剂。
Clin Ther. 2012 Jun;34(6):1209-20. doi: 10.1016/j.clinthera.2012.04.005. Epub 2012 Apr 21.
7
Ticagrelor for acute coronary syndromes.替格瑞洛用于急性冠状动脉综合征
Expert Rev Cardiovasc Ther. 2013 Nov;11(11):1473-84. doi: 10.1586/14779072.2013.839205. Epub 2013 Oct 23.
8
Lack of Effect of Platelet Transfusions and Desmopressin on Intracranial Bleeding in a Patient Receiving Ticagrelor.替格瑞洛治疗患者中血小板输注和去氨加压素对颅内出血的无效作用
A A Case Rep. 2015 Jun 15;4(12):169-71. doi: 10.1213/XAA.0000000000000156.
9
P2Y₁₂ receptor inhibitors: integrating ticagrelor into the management of acute coronary syndrome.P2Y₁₂ 受体抑制剂：替格瑞洛在急性冠状动脉综合征治疗中的应用。
Ann Pharmacother. 2011 Sep;45(9):1151-6. doi: 10.1345/aph.1Q141. Epub 2011 Aug 18.
10
Platelet reactivity measurements reveal patient noncompliance during ticagrelor maintenance therapy.血小板反应性测量揭示了替格瑞洛维持治疗期间患者的不依从性。
Can J Cardiol. 2013 Dec;29(12):1743.e13-4. doi: 10.1016/j.cjca.2013.09.016.

引用本文的文献

1
Early vs Delayed Bypass Surgery in Patients With Acute Coronary Syndrome Receiving Ticagrelor: The RAPID CABG Randomized Open-Label Noninferiority Trial.替格瑞洛治疗的急性冠脉综合征患者早期与延迟搭桥手术：RAPID CABG随机开放标签非劣效性试验
JAMA Surg. 2025 Apr 1;160(4):387-394. doi: 10.1001/jamasurg.2024.7066.
2
How to undertake procedures while on antiplatelet agents: a hematologist's view.服用抗血小板药物时如何进行手术：血液科医生的观点。
Res Pract Thromb Haemost. 2024 Aug 5;8(6):102539. doi: 10.1016/j.rpth.2024.102539. eCollection 2024 Aug.
3
Reversal of Platelet Inhibition in Patients Receiving Ticagrelor.
接受替格瑞洛治疗的患者血小板抑制作用的逆转
Rev Cardiovasc Med. 2022 Sep 5;23(9):300. doi: 10.31083/j.rcm2309300. eCollection 2022 Sep.
4
ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic events.ANMCO/SIMEU关于在有持续出血或出血事件高风险患者中使用抗血栓治疗逆转剂的共识文件。
Eur Heart J Suppl. 2024 May 16;26(Suppl 2):ii211-ii220. doi: 10.1093/eurheartjsupp/suae033. eCollection 2024 Apr.
5
Progress in the clinical effects and adverse reactions of ticagrelor.替格瑞洛的临床疗效及不良反应研究进展
Thromb J. 2024 Jan 10;22(1):8. doi: 10.1186/s12959-023-00559-3.
6
Ticagrelor inverse agonist activity at the P2Y receptor is non-reversible versus its endogenous agonist adenosine 5´-diphosphate.替格瑞洛对 P2Y 受体的反向激动剂活性与内源性激动剂腺苷 5´-二磷酸相比是非可逆的。
Br J Pharmacol. 2024 Jan;181(1):21-35. doi: 10.1111/bph.16204. Epub 2023 Sep 1.
7
Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet Agents.血小板模拟纳米海绵用于抗血小板药物功能逆转。
Circ Res. 2023 Feb 3;132(3):339-354. doi: 10.1161/CIRCRESAHA.122.321034. Epub 2023 Jan 10.
8
The Perioperative Management of Antiplatelet and Anticoagulant Drugs in Hip Fractures: Do the Surgery as Early as Possible.髋部骨折围手术期抗血小板和抗凝药物的管理：尽早进行手术。
Arch Bone Jt Surg. 2022 Jun;10(6):490-500. doi: 10.22038/ABJS.2021.56396.2800.
9
Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbent.使用多孔聚合物珠吸附剂从全血中去除抗血栓药物。
Eur Heart J Cardiovasc Pharmacother. 2022 Dec 2;8(8):847-856. doi: 10.1093/ehjcvp/pvac036.
10
Antiplatelet Therapy for Atherothrombotic Disease in 2022-From Population to Patient-Centered Approaches.2022年动脉粥样硬化血栓形成性疾病的抗血小板治疗——从群体到以患者为中心的方法
Front Cardiovasc Med. 2022 Jan 28;9:805525. doi: 10.3389/fcvm.2022.805525. eCollection 2022.